In this webinar, cardiologist Martha Grogan, MD, and hematologist Prashant Kapoor, MD, provide an overview of amyloidosis, including tests and evaluations, treatment options and how to manage your symptoms. A question and answer session followed the presentation.
Would you like to:
Are all MGUS, Smoldering Myeloma and Myeloma patients tested for Amyloidosis at outset/initial evaluation? or must a patient present overt symptoms before the suspicion to test arises. Can it be tested for before overt symptoms present? Should it be tested for in this setting (MGUS, SMM, MM) before overt symptoms present and organ damage has already occurred?
If you have had a SCT and achieved complete clinical remission and then after several years have elevated light chains, do you ever suggest a second SCT? Or, is other treatment preferred? If you do suggest second SCT process, what are the decision points? If not SCT, what other treatment is your preference?
@nicolebennettengler
Wonderful to hear! We very much appreciate this feedback.